Evolution of the Average Target: CEVA, Inc.

Evolution of the Target Price: CEVA, Inc.

Changes in Analyst Recommendations: CEVA, Inc.

30d4144410bf8eadf41c1e.VQbpwwvSQG7JqwcQj4tngUVVAcp7coZ3gsoMvJS2P9M.Y1HY-kKiAVfwynVE9ugm1WgjaqkKJvQBs5lfjfPPbrEtVrahQqVxNPzNPw~af5ce0797a13068968958a1fff04a6ee
08-11 Oppenheimer Adjusts CEVA Price Target to $38 From $42, Maintains Outperform Rating MT
07-16 Benchmark Initiates CEVA at Hold MT
06-15 Needham Initiates CEVA at Buy With $55 Price Target MT
05-12 UBS Adjusts Price Target on CEVA to $48 From $42, Maintains Buy Rating MT
05-12 Oppenheimer Adjusts CEVA Price Target to $42 From $30, Maintains Outperform Rating MT
05-08 JPMorgan Initiates Coverage on CEVA With Neutral Rating, $30 Price Target MT
05-04 UBS Adjusts Price Target on CEVA to $42 From $27, Maintains Buy Rating MT
02-25 UBS Initiates CEVA at Buy With $27 Price Target MT
02-18 Oppenheimer Adjusts CEVA Price Target to $30 From $33, Maintains Outperform Rating MT
02-10 Stifel Initiates CEVA at Buy With $30 Price Target MT
12-01 Loop Capital Initiates Coverage on CEVA With Buy Rating, $28 Price Target MT
09/05/25 Oppenheimer Adjusts CEVA Price Target to $33 From $40, Maintains Outperform Rating MT
14/02/25 Oppenheimer Adjusts Price Target on CEVA to $40 From $36, Keeps Outperform Rating MT
13/02/25 Barclays Raises Price Target on CEVA to $40 From $34, Maintains Overweight Rating MT
07/11/24 Barclays Raises Price Target on CEVA to $34 From $29, Maintains Overweight Rating MT
08/08/24 Oppenheimer Raises CEVA Price Target to $33 From $29, Maintains Outperform Rating MT
08/08/24 Roth MKM Upgrades CEVA to Buy From Neutral, Raises Price Target to $25 From $20 MT
15/02/24 Oppenheimer Adjusts CEVA Price Target to $29 From $25, Maintains Outperform Rating MT
10/08/23 Northland Adjusts Price Target on CEVA to $30 From $35, Keeps Outperform Rating MT
10/08/23 Barclays Adjusts Price Target on CEVA to $29 From $32, Maintains Overweight Rating MT
10/08/23 Rosenblatt Adjusts CEVA's Price Target to $35 From $45, Keeps Buy Rating MT
10/08/23 Roth MKM Downgrades CEVA to Neutral From Buy, Adjusts Price Target to $20 From $30 MT
11/05/23 Roth MKM Adjusts CEVA's Price Target to $30 From $40, Keeps Buy Rating MT
11/05/23 TD Cowen Adjusts Price Target on CEVA to $30 From $40, Maintains Outperform Rating MT
11/05/23 Oppenheimer Adjusts CEVA Price Target to $35 From $40, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+67.97%
+40.53%
+35.97%
+44.58%
+55.67%
+87.23%
+30.6%
+24.69%
+14.11%
+21.87%
Average +42.32%
Weighted average by Cap. +42.84%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
28.13USD
Average target price
47.25USD
Spread / Average Target
+67.97%
High Price Target
60.00USD
Spread / Highest target
+113.30%
Low Price Target
38.00USD
Spread / Lowest Target
+35.09%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Oppenheimer
Benchmark Company
Needham & Co.
UBS
JPMorgan Chase
Stifel Nicolaus
Loop Capital
Barclays
Northland Securities
Roth MKM
Rosenblatt Securities
TD Cowen
Roth Capital Partners
Cowen
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
28.13USD
Average target price
47.25USD
Spread / Average Target
+67.97%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVA Stock
  4. Consensus CEVA, Inc.